[
  {
    "ts": null,
    "headline": "Sage Therapeutics: A Speculative Play That Needs To Wait For A Turnaround Story",
    "summary": "Sage Therapeutics faces challenges with a 90% value drop but shows promise with Zurzuvae for postpartum depression. Click here to read my most recent analysis on SAGE.",
    "url": "https://finnhub.io/api/news?id=e63892e7a791faa93da005997d66ac8df4fdfcb3851e6d722a9f0a524a2beb0d",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744218672,
      "headline": "Sage Therapeutics: A Speculative Play That Needs To Wait For A Turnaround Story",
      "id": 133838928,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/686933011/image_686933011.jpg?io=getty-c-w1536",
      "related": "BIIB",
      "source": "SeekingAlpha",
      "summary": "Sage Therapeutics faces challenges with a 90% value drop but shows promise with Zurzuvae for postpartum depression. Click here to read my most recent analysis on SAGE.",
      "url": "https://finnhub.io/api/news?id=e63892e7a791faa93da005997d66ac8df4fdfcb3851e6d722a9f0a524a2beb0d"
    }
  },
  {
    "ts": null,
    "headline": "Biogen Inc. stock rises Wednesday, still underperforms market",
    "summary": "Biogen Inc. stock rises Wednesday, still underperforms market",
    "url": "https://finnhub.io/api/news?id=decf95059ecf3b0a14682162a2c5a8837dafd88f0d797986244d8d40193b043b",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744218420,
      "headline": "Biogen Inc. stock rises Wednesday, still underperforms market",
      "id": 133866355,
      "image": "",
      "related": "BIIB",
      "source": "MarketWatch",
      "summary": "Biogen Inc. stock rises Wednesday, still underperforms market",
      "url": "https://finnhub.io/api/news?id=decf95059ecf3b0a14682162a2c5a8837dafd88f0d797986244d8d40193b043b"
    }
  },
  {
    "ts": null,
    "headline": "Sage Therapeutics: Biogen's $7.22/Share Bid Might Say More Than The Price Tag",
    "summary": "Sage Therapeutics: Biogen's $7.22/Share Bid Might Say More Than The Price Tag",
    "url": "https://finnhub.io/api/news?id=463b4dc6d1d5cc98cb8238b60c43144a886bf56b84323122e66413b033e31539",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744176878,
      "headline": "Sage Therapeutics: Biogen's $7.22/Share Bid Might Say More Than The Price Tag",
      "id": 133826368,
      "image": "",
      "related": "BIIB",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=463b4dc6d1d5cc98cb8238b60c43144a886bf56b84323122e66413b033e31539"
    }
  }
]